Recommended Dosing Strengths for Systemic Antifungal Agents
For adults without renal or hepatic impairment, the standard dosing strengths vary by antifungal class and clinical indication, with echinocandins requiring loading doses followed by maintenance doses, azoles typically dosed at 200-400 mg daily depending on infection severity, and amphotericin B dosed at 0.3-1 mg/kg daily based on the specific formulation and infection type.
Echinocandins (First-Line for Most Invasive Candidiasis)
The echinocandins require loading doses to achieve therapeutic levels rapidly 1:
- Caspofungin: 70 mg loading dose, then 50 mg daily
- Micafungin: 100 mg daily (no loading dose required for most indications; 150 mg daily for esophageal candidiasis)
- Anidulafungin: 200 mg loading dose, then 100 mg daily
These agents do not require dose adjustment for renal or hepatic impairment 2, making them particularly practical in critically ill patients where organ function may be fluctuating.
Azoles (Fluconazole Most Common)
Fluconazole dosing is indication-specific 1:
For Invasive Candidiasis/Candidemia:
- 800 mg loading dose, then 400 mg (6 mg/kg) daily for step-down therapy after echinocandin initiation
For Oropharyngeal Candidiasis:
- Mild disease: 100-200 mg daily for 7-14 days
- Moderate-severe disease: 100-200 mg daily for 7-14 days 1
For Esophageal Candidiasis:
- 200-400 mg (3-6 mg/kg) daily for 14-21 days 1
For Urinary Tract Infections:
- Cystitis: 200 mg (3 mg/kg) daily for 2 weeks 1
- Pyelonephritis: 200-400 mg (3-6 mg/kg) daily for 2 weeks 1
Alternative Azoles for Refractory Disease:
- Itraconazole solution: 200 mg once daily 1
- Posaconazole suspension: 400 mg twice daily for 3 days, then 400 mg daily (up to 28 days) 1
- Voriconazole: 200 mg twice daily 1
Amphotericin B Formulations
Dosing varies significantly by formulation 1:
Amphotericin B Deoxycholate:
- For invasive candidiasis: 0.3-0.7 mg/kg daily
- For urinary tract infections: 0.3-0.6 mg/kg daily for 1-7 days
- For neonatal disseminated candidiasis: 1 mg/kg daily
Lipid Formulations:
- Liposomal amphotericin B: 3-5 mg/kg daily (use with caution in urinary tract involvement due to poor urinary penetration)
Flucytosine (Adjunctive Therapy)
- 25 mg/kg four times daily (typically combined with amphotericin B for resistant organisms like fluconazole-resistant C. glabrata) 1
Critical Considerations
Loading Doses Are Essential
The 2016 IDSA guidelines consistently emphasize loading doses for both echinocandins and fluconazole when treating serious infections 1. Failure to use loading doses delays achievement of therapeutic concentrations and may compromise outcomes.
Therapeutic Drug Monitoring
The 2025 ECMM guideline 3 recommends TDM-guided dosing for triazoles in high-risk populations (critically ill patients, altered volume of distribution, hypoalbuminemia, drug-drug interactions, obesity). For echinocandins, target trough Cmin >1 mg/L is considered adequate, though TDM is less established 3.
Common Pitfall: Underdosing
Many clinicians fail to use appropriate loading doses or adequate maintenance doses, particularly for fluconazole in invasive disease. The standard 400 mg daily maintenance dose (after 800 mg load) is critical for adequate tissue penetration 1.
Species-Specific Considerations
- For C. krusei: Amphotericin B 0.3-0.6 mg/kg daily (fluconazole-resistant) 1
- For fluconazole-resistant C. glabrata: Echinocandin preferred, or amphotericin B 0.3-0.6 mg/kg daily ± flucytosine 1
No Dose Adjustment Needed
Anidulafungin specifically does not require dose adjustment for any degree of hepatic or renal impairment 2, making it an excellent choice when organ dysfunction complicates dosing decisions.